Genmab Net Income Applicable To Common Shares from 2010 to 2026
| GE9 Stock | EUR 274.90 0.50 0.18% |
Net Income Applicable To Common Shares | First Reported 2016-12-31 | Previous Quarter 1.4 B | Current Value 1.4 B | Quarterly Volatility 800.2 M |
Check Genmab A/S financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genmab A/S's main balance sheet or income statement drivers, such as Discontinued Operations of 33.8 M, Interest Expense of 0.0 or Selling General Administrative of 413 M, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0 or PTB Ratio of 2.25. Genmab financial statements analysis is a perfect complement when working with Genmab A/S Valuation or Volatility modules.
Genmab | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for Genmab AS offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Genmab A/S is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Genmab A/S's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Genmab AS over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Genmab A/S's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genmab A/S's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Genmab Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 2,634,882,235 | |
| Geometric Mean | 1,175,517,350 | |
| Coefficient Of Variation | 94.95 | |
| Mean Deviation | 2,224,228,159 | |
| Median | 1,472,000,000 | |
| Standard Deviation | 2,501,692,132 | |
| Sample Variance | 6258463.5T | |
| Range | 6.6B | |
| R-Value | 0.95 | |
| Mean Square Error | 687514.8T | |
| R-Squared | 0.90 | |
| Slope | 469,205,353 | |
| Total Sum of Squares | 100135416.4T |
Genmab Net Income Applicable To Common Shares History
About Genmab A/S Financial Statements
Genmab A/S stakeholders use historical fundamental indicators, such as Genmab A/S's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Genmab A/S investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genmab A/S's assets and liabilities are reflected in the revenues and expenses on Genmab A/S's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genmab AS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 6.4 B | 6.7 B |
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Check out the analysis of Genmab A/S Correlation against competitors. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.